This site is intended for healthcare professionals
FDA Hero Banner - Multi-coloured pills and tablets
FDA Drug information

Carbon Dioxide

Read time: 1 mins
Marketing start date: 27 Apr 2024
...
 

Summary of product characteristics


Effective Time

20231010

Version

3

Spl Product Data Elements

Carbon Dioxide Carbon Dioxide CARBON DIOXIDE CARBON DIOXIDE

Application Number

NDA216614

Brand Name

Carbon Dioxide

Generic Name

Carbon Dioxide

Product Ndc

63961-010

Product Type

HUMAN PRESCRIPTION DRUG

Route

RESPIRATORY (INHALATION)

Package Label Principal Display Panel

REFRIGERATED LIQUID CARBON DIOXIDE, REFRIGERATED LIQUID USP UN2187 MiddlesexGases WARNING: USP Rx Only Administration of Carbon Dioxide may be hazardous or contraindicated. For use only by or under the supervision of a licensed practitioner who is experienced in the use and administration of Carbon Dioxide and is familiar with the indications, effects, dosages, methods, and frequency and duration of administration, and with the hazards, contraindications and side effects, and the precautions to be taken. CONTENTS: LOT NO. Middlesex Gases & Technologies 292 2nd St. Everett, MA 02149 617-387-5050 WARNING: INJURY. MAY DISPLACE OXYGEN AND CAUSE RAPID SUFFOCATION. MAY INCREASE RESPIRATION AND HEART RATE. Do not handle until all safety precautions have been read and understood. Use and store only outdoors or in a well-ventilated place. Wear cold insulating gloves, face shield, and eye protection. Use a back flow preventive device in the piping. DO NOT change or force fit connections. Close valve after each use and when empty. Always keep container in upright position. Read and follow the Safety Data Sheet (SDS) before use. FIRST AID: IF INHALED: Remove person to fresh air and keep comfortable for breathing. IF ON SKIN: Thaw frosted parts with lukewarm water. Do not rub affected area. Get immediate medical advice/attention. CAS: 124-38-9 DO NOT REMOVE THIS PRODUCT LABEL. carbon dioxide one

Drug section

CME banner

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.

Click here to view

Disclaimer

The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).

Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.

Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.